Is Certara (CERT) Offering Opportunity After Prolonged Share Price Weakness

If you are looking at Certara and wondering whether the recent share price offers value or just more risk, you are not alone. The stock closed at US$6.65, with a 7 day return of a 5.8% decline, a 30 ...

Cytokinetics Teases Q2 ACACIA-HCM Catalyst as MYQORZO Launch Gains Momentum at Leerink Conference

Cytokinetics (NASDAQ:CYTK) used its presentation at the Leerink Global Healthcare Conference to outline its transition from a long-running research-focused company into a commercial-stage ...